Pheophytin a isolated from the seagrass Syringodium isoetifolium plausibly blocks umuC proteins of select bacterial pathogens, in silico.

AIMS: This investigation is designed to evaluate the antibacterial efficiency of the noodle grass Syringodium isoetifolium, which is commonly found in the Indian coastal waters. Also, this study characterizes the active compound and predicts the mode of action in silico. METHODS AND RESULTS: Human pathogenic bacteria were treated with crude metabolites of S. isoetifolium. The potent fraction b was analysed by UV/VIS, Spectroscopy RP-HPLC, FT-IR, ESI-Mass and 1 H and 13 C NMRs and determined to be a hydrate of pheophytin a (C55 H74 N4 O6 ). The isolated compound Pheo had MIC values of 6·2 ± 0·7 (Salmonella typhi) and 12·5 ± 0·8 (Escherichia coli and Pseudomonas aeruginosa) µg ml-1 . Molecular docking studies of the compound were done to find the binding sites on the pathogens using a Molegro Virtual Docker platform. Pheo targets umuC proteins by binding compactly to five amino acid residues with interaction energy of -3·66 and a Moldock score of -160·175. CONCLUSIONS: Hence, we conclude that pheophytin a, besides being an accessory photosynthetic pigment, also has proven to be antibacterial against human pathogens. Lesser MIC values with definite binding sites predicted in silico are suggestive of a precise of action for this compound. SIGNIFICANCE AND IMPACT OF THE STUDY: Easy extraction methods of the active compound that has a definite target render this under-explored seagrass a good source of antibacterial compound against human pathogenic bacteria. This learning may favour more researches in this unexplored area to build up Pheo-based natural products as antibiotic therapies.

Fibrin hydrogels functionalized with cartilage extracellular matrix and incorporating freshly isolated stromal cells as an injectable for cartilage regeneration.

UNLABELLED: Freshly isolated stromal cells can potentially be used as an alternative to in vitro expanded cells in regenerative medicine. Their use requires the development of bioactive hydrogels or scaffolds which provide an environment to enhance their proliferation and tissue-specific differentiation in vivo. The goal of the current study was to develop an injectable fibrin hydrogel functionalized with cartilage ECM microparticles and transforming growth factor (TGF)-ß3 as a putative therapeutic for articular cartilage regeneration. ECM microparticles were produced by cryomilling and freeze-drying porcine articular cartilage. Up to 2% (w/v) ECM could be incorporated into fibrin without detrimentally affecting its capacity to form stable hydrogels. To access the chondroinductivity of cartilage ECM, we compared chondrogenesis of infrapatellar fat pad-derived stem cells in fibrin hydrogels functionalized with either particulated ECM or control gelatin microspheres. Cartilage ECM particles could be used to control the delivery of TGF-ß3 to IFP-derived stem cells within fibrin hydrogels in vitro, and furthermore, led to higher levels of sulphated glycosaminoglycan (sGAG) and collagen accumulation compared to control constructs loaded with gelatin microspheres. In vivo, freshly isolated stromal cells generated a more cartilage-like tissue within fibrin hydrogels functionalized with cartilage ECM particles compared to the control gelatin loaded constructs. These tissues stained strongly for type II collagen and contained higher levels of sGAGs. These results support the use of fibrin hydrogels functionalized with cartilage ECM components in single-stage, cell-based therapies for joint regeneration. STATEMENT OF SIGNIFICANCE: An alternative to the use of in vitro expanded cells in regenerative medicine is the use of freshly isolated stromal cells, where a bioactive scaffold or hydrogel is used to provide an environment that enhances their proliferation and tissue-specific differentiation in vivo. The objective of this study was to develop an injectable fibrin hydrogel functionalized with cartilage ECM micro-particles and the growth factor TGF-ß3 as a therapeutic for articular cartilage regeneration. This study demonstrates that freshly isolated stromal cells generate cartilage tissue in vivo when incorporated into such a fibrin hydrogels functionalized with cartilage ECM particles. These findings open up new possibilities for in-theatre, single-stage, cell-based therapies for joint regeneration.